Omar Khalil

Omar Khalil is a Managing Director at Santé Ventures in Boston, USA, where he manages the local office and leads biotechnology investments across various therapeutic areas and modalities. Before rejoining the venture capital firm in 2020, he held senior operational leadership positions at Baxter International, Baxalta (now Takeda), and Kaléo. During his tenure in the pharmaceutical and biotech industries, he successfully scaled businesses from early clinical development to generate over $3 billion in annual sales. Earlier in his career, he advised healthcare clients on growth and mergers at McKinsey & Company and earned both his master's and bachelor's degrees in biomedical engineering from the University of Michigan. Khalil currently focuses on partnering with scientific founders to advance innovative therapies, leveraging his deep operational experience to bridge clinical science, business strategy, and venture capital investment.